Golden State Equity Partners’s Sanofi SNY Stock Holding History

Golden State Equity Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.14K	Sell	144 -6,669	-98%	-$298K	0.02%	243
2026 Q1	$328K	Buy	6,813 +1,126	+20%	+$52.5K	0.02%	556
2025 Q4	$276K	Buy	5,687 +940	+20%	+$46.6K	0.04%	415
2025 Q3	$224K	Sell	4,747 -835	-15%	-$40.3K	0.04%	407
2025 Q2	$270K	Buy	5,582 +1,139	+26%	+$58.2K	0.05%	355
2025 Q1	$246K	Buy	+4,443	New	+$240K	0.05%	371
2024 Q4	–	Sell	-2,316	Closed	-$133K	–	806
2024 Q3	$133K	Buy	+2,316	New	+$125K	0.02%	447
2022 Q1	$442K	Buy	+8,600	New	+$444K	0.22%	114

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Golden State Equity Partners's SNY Position: Q2 2026 in Review

Golden State Equity Partners reduced its Sanofi (SNY) stake by 98% in Q2 2026, selling an estimated $298K and leaving 144 shares worth $6.14K. The position accounts for 0.02% of the portfolio, ranked #243.

Golden State Equity Partners first reported a position in SNY in Q1 2022 and has held it in 8 quarters since. The position peaked at $442K in Q1 2022. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Golden State Equity Partners held 144 shares of Sanofi worth $6.14K as of Q2 2026.
Golden State Equity Partners sold 6,669 Sanofi shares in Q2 2026, an estimated $298K.
Sanofi made up 0.02% of Golden State Equity Partners's portfolio in Q2 2026, its #243 holding.
Golden State Equity Partners first reported a position in Sanofi in Q1 2022 and has held it in 8 quarters since.
Golden State Equity Partners's Sanofi position peaked at $442K in Q1 2022.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.